MICHAEL DISIMONE: Open Payments
NPI 1104801497 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,129 in 105 payments from 18 companies in 2025. Trend: 2023 $1,143 · 2024 $2,374 · 2025 $2,129
Food & beverage: $2,129
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $483 |
| Janssen Biotech, Inc. | 14 | $298 |
| GENZYME CORPORATION | 6 | $169 |
| Novartis Pharmaceuticals Corporation | 6 | $150 |
| E.R. Squibb & Sons, L.L.C. | 19 | $146 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $115 |
| Arcutis Biotherapeutics, Inc. | 6 | $103 |
| LEO Pharma Inc. | 3 | $85 |
| UCB, Inc. | 4 | $84 |
| Amgen Inc. | 3 | $79 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, RINVOQ, Sotyktu, Zoryve, ADBRY, Bimzelx.
Industry payments across VA — which companies pay providers there.
